Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join us on the latest episode! Our Guest: Michael Oleksiw, CEO at Pleio.
What you'll get out of this episode:
- Human + AI Synergy: Pleio combines emotionally aware AI with peer-to-patient support to boost medication adherence.
- Overcoming Emotional Barriers: Emotions like fear, loneliness, and stigma are major challenges after diagnosis.
- Real-World Impact: Pleio's approach improved adherence rates by up to 28% in GLP-1 medication trials.
- Ethical AI in Healthcare: Patient data is de-identified and overseen by a medical board to ensure ethical use.
- Laser Focus on Loneliness: Pleio’s next frontier is tackling loneliness as a primary emotional barrier in healthcare.
To Learn More About Our Guest And Their Company:
Guest LinkedIn https://www.linkedin.com/in/michaeloleksiw/
Company LinkedIn https://www.linkedin.com/company/pleio-inc/
Website http://www.pleio.com
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/